

Please note: Product illustrations may slightly vary. If you have any questions about a product or service, please consult a healthcare professional. We are happy to assist you.
Please note: Product illustrations may slightly vary. If you have any questions about a product or service, please consult a healthcare professional. We are happy to assist you.
-
Please note that an additional risk assessment consultation fee of £30 is payable at the pharmacy. This is only applicable per visit and is charged separately from the cost of the vaccine.
Be prepared against chikungunya — a painful, mosquito-borne virus — with the most advanced vaccines now available.
-
Vaccine Type:
We offer two safe and effective options depending on eligibility: -
IXCHIQ (live attenuated) – approved for adults 18 and over
-
Vimkunya (virus-like particle, VLP) – approved for people 12 years and over
-
Why it matters:
Chikungunya causes sudden fever and intense joint pain, which can linger for months or years. Both vaccines prompt a strong immune response (seroprotection rates around 98%) one month post-vaccination. - Safety Considerations:
-
For IXCHIQ, use is paused or restricted for older adults (typically 60–65+), due to rare but serious adverse events particularly in older populations. Alternatives are available.
-
Vimkunya has shown more consistent responses across age groups, including older adults, with fewer safety restrictions.
-
When to consider vaccination:
Ideal for those travelling to or spending extended time in regions where chikungunya is spreading — such as parts of Asia, Africa, the Americas, and the Pacific.
Vaccination requires a prescription and must follow a consultation with a healthcare provider to determine the appropriate vaccine based on age, health status, and travel plans. Side effects may include injection-site soreness, fever, muscle and joint pain, fatigue, or headache.
Why choose us:
We offer the latest chikungunya vaccines authorised in the UK, providing real protection and peace of mind — especially for travellers planning trips to high-risk regions. -
Vaccine Type:
Please note that an additional risk assessment consultation fee of £30 is payable at the pharmacy. This is only applicable per visit and is charged separately from the cost of the vaccine.
Be prepared against chikungunya — a painful, mosquito-borne virus — with the most advanced vaccines now available.
-
Vaccine Type:
We offer two safe and effective options depending on eligibility: -
IXCHIQ (live attenuated) – approved for adults 18 and over
-
Vimkunya (virus-like particle, VLP) – approved for people 12 years and over
-
Why it matters:
Chikungunya causes sudden fever and intense joint pain, which can linger for months or years. Both vaccines prompt a strong immune response (seroprotection rates around 98%) one month post-vaccination. - Safety Considerations:
-
For IXCHIQ, use is paused or restricted for older adults (typically 60–65+), due to rare but serious adverse events particularly in older populations. Alternatives are available.
-
Vimkunya has shown more consistent responses across age groups, including older adults, with fewer safety restrictions.
-
When to consider vaccination:
Ideal for those travelling to or spending extended time in regions where chikungunya is spreading — such as parts of Asia, Africa, the Americas, and the Pacific.
Vaccination requires a prescription and must follow a consultation with a healthcare provider to determine the appropriate vaccine based on age, health status, and travel plans. Side effects may include injection-site soreness, fever, muscle and joint pain, fatigue, or headache.
Why choose us:
We offer the latest chikungunya vaccines authorised in the UK, providing real protection and peace of mind — especially for travellers planning trips to high-risk regions.